Veterinary Medicines

ADEQUAN IM 500 MG/5 ML SOLUTION FOR INJECTION

Authorised
  • GLYCOSAMINOGLYCAN POLYSULFATE
Download as PDF

Product identification

Medicine name:
ADEQUAN IM 500 MG/5 ML SOLUTION FOR INJECTION
ADEQUAN INTRAMUSCULAIRE 500 MG/5 ML SOLUTION INJECTABLE
Active substance:
  • GLYCOSAMINOGLYCAN POLYSULFATE
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • GLYCOSAMINOGLYCAN POLYSULFATE
    500.00
    milligram(s)
    /
    1.00
    Bottle
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AX12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Cardboard box with 7 neutral glass vials of 5 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Daiichi Sankyo Altkirch
Marketing authorisation date:
Manufacturing sites for batch release:
  • Klifovet GmbH
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1652552 8/1999
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0416/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 15/02/2024
Download
French (PDF)
Published on: 9/07/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 27/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."